You are searching for: hsa04218

---

T62449 Target Info	Target Name	Checkpoint kinase-1 (CHK1)
	Target type	Clinical trial Target
	Disease	Non-small-cell lung cancer; Small-cell lung cancer;
	Drugs	UCN-01	Drug Info

T49898 Target Info	Target Name	Cyclin-dependent kinase 1 (CDK1)
	Target type	Clinical trial Target
	Disease	Breast cancer; Non-small-cell lung cancer;
	Drugs	P276-00	Drug Info

T70176 Target Info	Target Name	Cyclin-dependent kinase 2 (CDK2)
	Target type	Clinical trial Target
	Disease	Thymic cancer; Anaplastic astrocytoma;
	Drugs	R-roscovitine	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T14731 Target Info	Target Name	NAD-dependent deacetylase sirtuin-1 (SIRT1)
	Target type	Clinical trial Target
	Disease	Rheumatoid arthritis; Systemic sclerosis;
	Drugs	Resveratrol	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T65864 Target Info	Target Name	Stress-activated protein kinase 2a (p38 alpha)
	Target type	Clinical trial Target
	Disease	Xerophthalmia; Acute coronary syndrome;
	Drugs	Ozagrel	Drug Info

T55729 Target Info	Target Name	Stress-activated protein kinase 2b (p38 beta)
	Target type	Clinical trial Target
	Disease	Alzheimer disease; Rheumatoid arthritis;
	Drugs	VX-745	Drug Info

T53389 Target Info	Target Name	TGF-beta receptor type I (TGFBR1)
	Target type	Clinical trial Target
	Disease	Arteriosclerosis; Non-small-cell lung cancer;
	Drugs	LY2157299	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.